This report contains market size and forecasts of Muscarinic Antagonist in global, including the following market information:
Global Muscarinic Antagonist Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Muscarinic Antagonist Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Muscarinic Antagonist companies in 2021 (%)
The global Muscarinic Antagonist market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Atropine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Muscarinic Antagonist include Aseptic Innovative Medicine, OSRX Pharmaceuticals, Tache Pharmacy, Wufu Laboratories, Singapore National Eye Centre, Shenyang Xingqi Pharmaceutical, Aier Eye Hospital Group, He Eye Specialist Hospital and Alkaloids of Australia, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Muscarinic Antagonist manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Muscarinic Antagonist Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Muscarinic Antagonist Market Segment Percentages, by Type, 2021 (%)
Atropine
Scopolamine
Glycopyrrolate
Ipratropium Bromide
Others
Global Muscarinic Antagonist Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Muscarinic Antagonist Market Segment Percentages, by Application, 2021 (%)
Hospital Use
Clinic Use
Others
Global Muscarinic Antagonist Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Muscarinic Antagonist Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Muscarinic Antagonist revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Muscarinic Antagonist revenues share in global market, 2021 (%)
Key companies Muscarinic Antagonist sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Muscarinic Antagonist sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aseptic Innovative Medicine
OSRX Pharmaceuticals
Tache Pharmacy
Wufu Laboratories
Singapore National Eye Centre
Shenyang Xingqi Pharmaceutical
Aier Eye Hospital Group
He Eye Specialist Hospital
Alkaloids of Australia
Boehringer Ingelheim
Fine Chemicals Corporation
Phytex Australia
Alchem International
Guangzhou Hanfang
Alkaloids Corporation
Luyin
Toobapharma
Infa Group
Suven Life Sciences Limited
Sharon
Tai Heng Industry Co., Ltd
Stellar Chemical Laboratories Pvt
Invent Farma
Wuhan Shengtianyu
AstraZeneca
Synapse Pharma
Vectura Group
Elan